Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 5/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.40 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | TRPV1 | Q8NER1 | 3/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7408029 | 1.00 | ALOX5 (0.47) | ALOX5POLBMAPK1SMN1; SMN2MEN1 | |
| SCHEMBL11001669 | 0.88 | POLB (0.50) | ALOX5POLBMAPK1SMN1; SMN2 | |
| SCHEMBL11000559 | 0.88 | POLB (0.50) | ALOX5POLBMAPK1SMN1; SMN2 | |
| SCHEMBL7324262 | 0.88 | POLB (0.50) | ALOX5POLBMAPK1SMN1; SMN2 | |
| SCHEMBL7327155 | 0.88 | POLB (0.50) | ALOX5POLBMAPK1SMN1; SMN2 | |
| SCHEMBL10556631 | 0.85 | ALOX5 (0.46) | ALOX5TRPV1 | |
| SCHEMBL27282340 | 0.85 | ALOX5 (0.43) | ALOX5POLBMAPK1SMN1; SMN2MEN1 | |
| SCHEMBL9638493 | 0.84 | TSHR (0.46) | ALOX5MAPK1MEN1KMT2AALDH1A1 | |
| SCHEMBL11001924 | 0.84 | POLB (0.47) | ALOX5POLBMAPK1SMN1; SMN2 | |
| SCHEMBL11000696 | 0.84 | POLB (0.47) | ALOX5POLBMAPK1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012022467-A2 | NOVEL BENZOQUINONE DERIVATIVES AND USE THEREOF AS MODULATORS OF MITOCHONDRIAL FUNCTION | SANTHERA PHARMACEUTICALS (SCHWEIZ) AG (CH) | 2012-02-23 | — | — | WO | disclosed |
| EP-0201196-B1 | BENZOQUINONE DERIVATIVES, THEIR PRODUCTION AND USE | Takeda Chemical Industries, Ltd. (JP) | 1991-07-03 | — | — | EP | disclosed |
| US-4897420-A | ISCHEMIC DISEASES; ANTIALLERGENS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1990-01-30 | — | — | US | disclosed |
| US-4842775-A | SODIUM BOROHYDRIDE IN PRESENCE OF ALUMINUM CHLORIDE AND WATER | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1989-06-27 | — | — | US | disclosed |
| EP-0201196-A2 | Benzoquinone derivatives, their production and use | Takeda Chemical Industries, Ltd. (JP) | 1986-11-12 | — | — | EP | disclosed |
| US-4559177-A | HYPOTENSIVE, CARDIOTONIC AND ANTIPHYLATIC AGENTS; ANTIALLERGENS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1985-12-17 | — | — | US | disclosed |
| US-4525361-A | FOR PHYSIOLOGICAL HOST DEFENSE CONTROL ACTIVITY IN MAMMALS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1985-06-25 | — | — | US | disclosed |
| EP-0021841-B1 | 2,3-DIALKOXY-1,4-QUINONE DERIVATIVES; METHOD OF PRODUCING 1,4-QUINONE DERIVATIVES | Takeda Chemical Industries, Ltd. (JP) | 1984-10-24 | — | — | EP | disclosed |
| US-4407757-A | IMMUNOLOGY AGENT, MUSCLE RELAXANT | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1983-10-04 | — | — | US | disclosed |
| US-4271083-A | IMMUNO-POTENTIATING ACTIVITY | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1981-06-02 | — | — | US | disclosed |
| EP-0021841-A2 | 2,3-Dialkoxy-1,4-quinone derivatives; method of producing 1,4-quinone derivatives | Takeda Chemical Industries, Ltd. (JP) | 1981-01-07 | — | — | EP | disclosed |
| US-4139545-A | IMMUNO-POTENTIATORS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1979-02-13 | — | — | US | disclosed |